NET LOSS PER SHARE

6 Months Ended

Jun. 30, 2023

Basic and diluted net loss per share attributable to common stockholders are calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended June 30,				Six Months Ended June 30,
	2023		2022		2023		2022
Net loss attributable to common stockholders, basic	$	(764,232)	$	(220,425)	$	(1,543,760)	$	(301,711)
Change in fair value of dilutive warrants	—		(334,843)		—		(858,173)
Net loss attributable to common stockholders, diluted	$	(764,232)	$	(555,268)	$	(1,543,760)	$	(1,159,884)

Weighted-average shares outstanding, basic	1,912,459,833		1,669,303,813		1,871,884,313		1,661,960,471
Private Placement Warrants using the treasury stock method	—		17,511,591		—		22,367,536
Weighted-average shares outstanding, diluted	1,912,459,833		1,686,815,404		1,871,884,313		1,684,328,007

Net loss per share:
Basic	$	(0.40)	$	(0.13)	$	(0.82)	$	(0.18)
Diluted	$	(0.40)	$	(0.33)	$	(0.82)	$	(0.69)

The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:


	June 30,
Excluded Securities	2023	2022
Private Placement Warrants to purchase common stock	44,350,000	—
Options outstanding to purchase common stock	34,849,933	46,268,897
RSUs outstanding	54,716,422	39,884,884
Employee stock purchase plan	8,764,624	4,482,280
If-converted common shares from convertible note	36,737,785	36,737,785
Total	179,418,764	127,373,846

The 5,786,834 and 2,090,140 shares of common stock equivalents subject to RSUs are excluded from the anti-dilutive table above as the underlying shares remain contingently issuable since the market or corporate performance conditions have not been satisfied as of June 30, 2023 and 2022, respectively.